Aristotle Atlantic Partners, LLC Gilead Sciences, Inc. Transaction History

Aristotle Atlantic Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.44 Million - $1.55 Million	-21,200 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $1.36 Million - $1.53 Million	-22,000 Reduced 50.93%	21,200 $1.43 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $1.19 Million - $1.33 Million	-19,000 Reduced 30.55%	43,200 $2.81 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $18,162 - $23,700	-300 Reduced 0.48%	62,200 $3.89 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $2.21 Million - $2.57 Million	-34,000 Reduced 35.23%	62,500 $4.43 Million
Q1 2018 Sep 10, 2018	BUY	$72.84 - $88.8 $7.03 Million - $8.57 Million	96,500 New	96,500 $7.28 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $7.03 Million - $8.57 Million	-96,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $6.87 Million - $8.06 Million	96,500	96,500 $6.91 Million

1,926

993M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.